Accutar Biotech

New York, United States · Founded 2015 · $28.0M raised

Headquarters
New York
Employees
11–50
Founded
2015
Business Model
B2B
Total Funding
$28.0M
Last Round
$28.0M Series BApr 2021
Rounds
2

About

Accutar Biotech is a clinical-stage, AI-empowered drug discovery company headquartered in Brooklyn, New York, founded in 2015 by CEO Jie Fan. The company applies deep learning and computational chemistry to explain the physical and chemical nature of biological systems, powering a pipeline of small-molecule and targeted protein degradation programs, including AC0682, which is in Phase 1 trials for ER-positive breast cancer.

Summary

Accutar Biotech is an Artificial Intelligence company based in New York, United States, founded in 2015. It has raised $28.0M in total across 2 rounds, most recently a $28.0M Series B round in Apr 2021. Investors include Yunfeng Capital and Coatue Management.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series BSeries BApr 2021

Sign up to see all 2 rounds

Series B — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Accutar Biotech on Indexed.vc
<a href="https://indexed.vc/companies/accutar-biotech"><img src="https://indexed.vc/api/badge/company/accutar-biotech" alt="Accutar Biotech on Indexed.vc" width="260" height="76" /></a>